论文部分内容阅读
第38届欧洲肝病年会(EASL)于2003年7月3日至7日在瑞士日内瓦举行。来自欧、美及亚洲2000余人参会,中国大陆代表30余人。本次年会议题广泛,涉及肝脏疾病的许多方面,包括分子细胞学、生物学基础、营养和代谢等。 在病毒性肝炎方面,德国Zeuzem博士详细报道了HBV、HCV病毒动力学。研究发现HBV、HCV半衰期分别为19～38小时和2～5小时,其每日复制量分别为10~(11)～10~(15)和10~(10)～10~(13);抗病毒治疗与病毒动力学之间的关系;抗病毒治疗效果及HBV DNA、HCV RNA的检测,涉及检测方法及灵敏度。在慢性乙型肝炎的抗病毒治疗上,英国Foster博士分析
The 38th Annual European Hepatic Disease Conference (EASL) was held in Geneva, Switzerland from July 3 to July 7, 2003. More than 2,000 people from Europe, the United States and Asia participated in the conference. More than 30 representatives from mainland China attended the conference. This annual meeting is a wide range of topics and covers many aspects of liver disease including molecular cytology, biology, nutrition and metabolism. In viral hepatitis, Dr. Zeuzem of Germany has reported HBV and HCV viral dynamics in detail. The study found that the half-lives of HBV and HCV were 19 to 38 hours and 2 to 5 hours respectively, and their daily replications were 10 ~ (11) ~ 10 ~ (15) and 10 ~ (10) ~ 10 ~ (13) The relationship between viral therapy and viral kinetics; antiviral therapy and HBV DNA, HCV RNA testing, testing methods and sensitivity involved. In the antiviral treatment of chronic hepatitis B, the British Dr. Foster analysis